Market›Health Care›Health Care Equipment & Supplies›Health Care Equipment
GLUCOTRACK INC

GCTK

$0.73Apr 26, 2021 – Apr 24, 2026
Health CareHealth Care Equipment & SuppliesHealth Care Equipment$1M
MVM
-$0.0M
TD Variance
-1.583

Every news event mapped to its market reaction — 101 events, 61 months of data. No predictions, just what happened.

PositiveNegativeNo data· Dot size = magnitude · Scroll to zoom · Drag to pan
Hover to inspect

Want the full written briefing?

The chart shows what moved — the briefing shows why. Sourced, dated, no hot takes.

Subscribe on Substack →

News Events

DateReturnCategorySourceHeadline
2023-04-06+808.6%newsCoinCodexGlucoTrack, Inc. (GCTK) Stock Forecast & Price Prediction 2026–2030 - CoinCodex
2025-09-11+127.9%legalSEC EDGARGCTK 8-K: 1.01, 3.02 (SEC Filing)
2024-11-13-79.8%newsSeeking AlphaGlucotrack announces pricing of $10M public offering
2024-04-16+71.0%newsSeeking AlphaGlucotrack announces expansion into epidural glucose monitoring solutions
2023-04-13-64.4%newsSeeking AlphaGlucoTrack stock plummets on $10M underwritten public offering of common stock
2023-04-13-64.4%newsSeeking AlphaGlucoTrack slumps ~35% after plans for common stock offering
2025-09-12+59.3%legalSEC EDGARGCTK 8-K: 1.01, 2.03, 3.02 (SEC Filing)
2025-09-12+59.3%newsTipRanksWhy GlucoTrack (GCTK) Stock Jumped Over 100% Today and What Comes Next - TipRanks
2025-01-14-49.3%legalSEC EDGARGCTK 8-K: 3.02 (SEC Filing)
2026-01-29-43.5%newsExec EdgeGlucotrack Announces 3 New Patents to Monitor Blood Glucose
2026-01-29-43.5%newsGlobeNewswireGlucotrack Announces USPTO Approval for Issuance of Patents for Proprietary CBGM Platform
2026-01-29-43.5%newsInvesting.comGlucotrack stock soars after USPTO approves patents for glucose monitoring tech - Investing.com
2026-01-29-43.5%newsStocktwitsWhy Did Glucotrack Stock Surge 12% Pre-Market Today? - Stocktwits
2026-01-29-43.5%newsStocksToTradeGlucoTrack’s Share Offering Spurs Market Activity​ - StocksToTrade
2026-01-29-43.5%newsStock TitanImplantable glucose sensor designed for 3 years, backed by new US patents - Stock Titan
2026-01-29-43.5%newsparameter.ioGlucotrack, Inc. (GCTK) stock: slides 30% despite trio of fresh USPTO patents for implantable CBGM platform - parameter.io
2025-06-12-39.9%newsSeeking AlphaGlucotrack announces 1-for-60 reverse stock split
2025-02-04-38.9%newsSeeking AlphaGlucotrack announces pricing of $3M public offering
2025-02-04-38.9%newsSeeking AlphaGlucotrack soars on completion of first human clinical study of continuous blood glucose monitor
2025-02-04-38.9%legalSEC EDGARGCTK 8-K: 5.03, 7.01, 8.01 (SEC Filing)
2025-02-04-38.9%newsStock TitanRevolutionary Blood Glucose Monitor Shows Promise: Direct Blood Measurement Could Transform Diabetes Care - Stock Titan
2026-03-30-36.9%newsGlobeNewswireGlucotrack Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Corporate Highlights
2026-03-30-36.9%earningsSeeking AlphaGlucotrack GAAP EPS of -$31.22
2026-03-30-36.9%legalSEC EDGARGCTK 8-K: 2.02 and (SEC Filing)
2026-03-30-36.9%newsStock TitanGlucotrack’s 3-year glucose implant targets a U.S. human trial in 2026 - Stock Titan
2026-03-30-36.9%newsStock TitanGlucotrack (NASDAQ: GCTK) trims 2025 loss and readies IDE for implantable CBGM trials - Stock Titan
2025-01-30-31.9%newsSeeking AlphaGlucotrack to execute 1-for-20 reverse stock split
2025-01-30-31.9%newsStock TitanGlucotrack's Strategic Move: 1-for-20 Reverse Split Could Save Nasdaq Listing - Stock Titan
2026-03-27-28.5%newsAssociated Press FinanceBC-Most Active Stocks
2026-03-27-28.5%earningsGlobeNewswireGlucotrack to File Significant IDE with FDA for US Clinical Trial in Early Q2 Based on Critical 2025 Milestones
2026-03-27-28.5%newsStock TitanBrazil and Australia trials put Glucotrack on path to a U.S. diabetes study - Stock Titan
2026-03-27-28.5%earningsMeykaGCTK stock GlucoTrack NASDAQ +29.80% on FDA IDE plan 27 Mar 2026: Earnings in focus - Meyka
2026-03-27-28.5%newstimothysykes.comUnexpected Stock Volatility: GCTK Faces Investor Concerns - timothysykes.com
2026-03-27-28.5%earningsparameter.ioGlucotrack, Inc. (GCTK) Stock: Prepares FDA Submission as Clinical Data Shows Strong Accuracy - parameter.io
2025-09-14-27.1%newsStocksToTradeGlucoTrack Shares Soar on Sixth Borough Capital Investment Surge​ - StocksToTrade
2025-09-13-27.1%newsStocksToTradeGlucoTrack Stock Soars on Sixth Borough Capital Fund Investment Commitment - StocksToTrade
2023-10-12-24.4%legalSEC EDGARGCTK 8-K: 5.02 and (SEC Filing)
2023-12-01+23.3%newsSeeking AlphaNasdaq grants additional 180 days to Glucotrack to regain compliance
2026-03-28-23.2%legalExec EdgeGlucotrack to File for FDA Exemption Based on 2025 Milestones
2024-11-14-22.8%legalSEC EDGARGCTK 8-K: 1.01, 3.02, 7.01, 8.01 (SEC Filing)
2025-01-29-22.1%legalSEC EDGARGCTK 8-K: 5.02, 7.01 (SEC Filing)
2025-09-02+19.6%newstimothysykes.comGlucoTrack Stock Soars: Is It Time to Buy? - timothysykes.com
2025-02-05-18.0%legalSEC EDGARGCTK 8-K: 1.01, 7.01 (SEC Filing)
2024-07-01-17.3%legalSEC EDGARGCTK 8-K: 1.01, 2.03, 3.02 (SEC Filing)
2026-04-14-17.1%legalSEC EDGARGCTK 8-K: 1.01, 2.03, 3.02 (SEC Filing)
2026-04-14-17.1%newsStock TitanGlucotrack (NASDAQ: GCTK) swaps $600K debt for 895,000 shares - Stock Titan
2025-12-31+13.0%legalSEC EDGARGCTK 8-K: 1.01, 3.02, 7.01 (SEC Filing)
2024-05-15-11.9%newsSeeking AlphaGlucotrack announces 1-for-5 reverse stock split
2025-11-13-10.9%earningsSeeking AlphaGlucotrack GAAP EPS of -$4.64
2025-11-13-10.9%legalSEC EDGARGCTK 8-K: 2.02 and (SEC Filing)
2022-03-16+9.6%newsTradingViewGCTK Stock Price and Chart — NASDAQ:GCTK - TradingView
2023-04-17-9.5%legalSEC EDGARGCTK 8-K: 1.01 and (SEC Filing)
2024-04-22-9.4%newsStock TitanGLUCOTRACK ANNOUNCES CLOSING OF PRIVATE PLACEMENT - Stock Titan
2025-03-31+8.8%legalSEC EDGARGCTK 8-K: 2.02, 7.01 (SEC Filing)
2024-09-23-8.5%legalSeeking AlphaGlucoTrack files for $30M mixed securities shelf
2024-07-22+8.2%legalSEC EDGARGCTK 8-K: 1.01, 2.03, 3.02 (SEC Filing)
2022-03-28-8.0%legalSEC EDGARGCTK 8-K: 5.02, 5.03 (SEC Filing)
2026-03-14-7.6%newsThe Globe and MailGlucoTrack Shareholders Approve Capital Flexibility and Auditor Ratification - The Globe and Mail
2022-03-14-7.3%newsSeeking AlphaGlucoTrack announces corporate name and ticker symbol change
2022-03-14-7.3%newsStock TitanLatest GCTK News - Glucotrack Announces Publication of Peer-Re... - Stock Titan
2026-04-21-7.1%newsExec EdgeStudy Supports GlucoTrack’s Blood Glucose Monitoring Implant
2026-04-21-7.1%newsGlobeNewswireGlucotrack Announces Publication of Peer-Reviewed Study Supporting Long-Life Sensor Design for Implantable Continuous Blood Glucose Monitoring Technology
2026-04-21-7.1%newsStock TitanOne-year lab test backs Glucotrack implantable glucose monitor - Stock Titan
2026-04-21-7.1%newsCổng thông tin điện tử tỉnh Lào CaiGlucoTrack (GCTK) Stock Investment Today (Volatility Increases) 2026-04-20 - Turnaround Stocks - Cổng thông tin điện tử tỉnh Lào Cai
2023-10-31-7.1%newsChartMillGCTK Stock Price, Quote & Chart | GLUCOTRACK INC (NASDAQ:GCTK) - ChartMill
2024-11-18-6.7%legalSEC EDGARGCTK 8-K: 1.01 and (SEC Filing)
2025-04-25+6.6%newsStock TitanGCTK Stock Price, News & Analysis - Stock Titan
2025-06-16+6.4%legalSEC EDGARGCTK 8-K: 5.03, 8.01 (SEC Filing)
2025-06-16+6.4%newsInvesting.comGlucotrack announces 1:60 reverse stock split - Investing.com
2026-03-10-6.3%newsGlobeNewswireGlucotrack to Present at LSI USA ’26 Medtech Innovation Summit
2026-03-10-6.3%newsStock TitanImplantable diabetes monitor, first human data at LSI USA '26 - Stock Titan
2024-01-02-6.3%newsSeeking AlphaGlucoTrack stock jumps 13% on preclinical update for glucose monitor
2024-01-02-6.3%legalSEC EDGARGCTK 8-K: 8.01 and (SEC Filing)
2024-12-17-6.0%legalSEC EDGARGCTK 8-K: 1.01 and (SEC Filing)
2022-10-10-5.8%newsSeeking AlphaGlucoTrack to start R&D program for glucose monitoring system
2026-04-16+5.6%newsUBND thành phố Hải PhòngShould You Hold GlucoTrack (GCTK) Stock? (Technical Weakness) 2026-04-16 - Popular Picks - UBND thành phố Hải Phòng
2024-06-20-4.9%legalSEC EDGARGCTK 8-K: 5.02, 5.03, 7.01 (SEC Filing)
2023-10-13-4.6%legalSEC EDGARGCTK 8-K: 8.01 and (SEC Filing)
2025-05-02+4.2%newsTradingKeyGCTK|GlucoTrack Inc|Price:0.729|Chg%:0.00 - TradingKey
2021-10-25-4.0%legalSEC EDGARGCTK 8-K: 5.02 and (SEC Filing)
2025-01-13+4.0%legalSEC EDGARGCTK 8-K: 3.02 (SEC Filing)
2024-09-03+3.8%legalSEC EDGARGCTK 8-K: 5.02, 7.01 (SEC Filing)
2025-06-04-3.7%newsIntellectia AIGCTK Forecast — Price Prediction for 2026. Should I Buy GCTK? - Intellectia AI
2023-08-31-3.4%legalSEC EDGARGCTK 8-K: 5.02 and (SEC Filing)
2024-07-31+2.9%legalSEC EDGARGCTK 8-K: 1.01, 2.03, 3.02, 5.02, 7.01 (SEC Filing)
2025-09-29-2.4%newsSeeking AlphaGlucoTrack files to sell 20.06M shares of common stock by selling shareholders
2026-04-18-2.2%newsQuiver QuantitativeGCTK | GlucoTrack, Inc. Common Stock Insider Trading - Quiver Quantitative
2025-05-14+2.1%legalSEC EDGARGCTK 8-K: 2.02, 7.01 (SEC Filing)
2024-09-10+1.4%legalSEC EDGARGCTK 8-K: 3.02 (SEC Filing)
2025-05-20-1.4%newsStock TitanGroundbreaking 3-Year Implantable Glucose Monitor Gets Patient-Led Development at Glucotrack - Stock Titan
2025-05-23-1.4%legalSEC EDGARGCTK 8-K: 5.02, 5.07 (SEC Filing)
2025-03-13+1.3%legalSEC EDGARGCTK 8-K: 3.02 (SEC Filing)
2025-05-15-1.1%earningsSeeking AlphaGlucotrack GAAP EPS of -$0.67
2025-12-30+0.9%newsStock TitanDiabetes tech firm lands $4M backing from single institutional investor - Stock Titan
2023-12-18-0.7%newsCNNsymbol__ Stock Quote Price and Forecast - CNN
2021-11-29+0.7%newsSeeking AlphaIntegrity Applications announces name change to Glucotrack, Inc.
2024-02-16+0.6%legalSEC EDGARGCTK 8-K: 2.01, 3.02 (SEC Filing)
2024-02-13+0.5%newsSeeking AlphaGlucotrack names Luis Malav board chair
2025-08-14-0.3%legalSEC EDGARGCTK 8-K: 2.02, 7.01 (SEC Filing)
2025-08-15+0.3%earningsSeeking AlphaGlucotrack GAAP EPS of -$9.62
2021-06-29-0.1%legalSEC EDGARGCTK 8-K: 5.02 (SEC Filing)
tickerdossier.comtickerdossier.substack.com